Polyethylene glycol interferon alpha-2b-induced immune-mediated polyradiculoneuropathy

Yuko Kato-Motozaki1, Kiyonobu Komai, Kazuya Takahashi

  • 1Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science, Kanazawa. yukokato@med.kanazawa-u.ac.jp

Summary

Polyethylene glycol-interferon alpha-2b (PEG-IFN alpha-2b) treatment for Hepatitis C Virus (HCV) may cause polyradiculoneuropathy. This condition is linked to anti-ganglioside antibodies, improving after treatment cessation and plasmapheresis.